SCHEMBL16019786

SCHEMBL16019786

Cc1cc2c(cc1-c1ccc(NC(=O)c3noc(C)c3C)cc1)OC(F)(F)O2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 1/20 0.43
▸ STIM1 Q13586 1/20 0.41
▸ ORAI1 Q96D31 1/20 0.41
▸ TAS2R8 Q9NYW2 1/20 0.40
▸ POLQ O75417 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ NFKB1 P19838 2/20 0.37
▸ NFKB2 Q00653 2/20 0.37
▸ RELA Q04206 2/20 0.37
▸ TP53 P04637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14887346 0.90 SMN1; SMN2 (0.44) STIM1ORAI1TAS2R8ADORA3ADORA2A
SCHEMBL14881326 0.85 GFER (0.52) TAS2R8KMT2AMEN1NPC1RAB9A
SCHEMBL14887339 0.83 BACE1 (0.44) SCN9ASTIM1ORAI1POLQSMN1; SMN2
SCHEMBL16019820 0.83 KDM4E (0.54) SCN9ASTIM1ORAI1POLQNPC1
SCHEMBL14887768 0.82 TP53 (0.40) SCN9ASTIM1ORAI1TAS2R8ADORA3
SCHEMBL16019818 0.82 CYP1A2 (0.46) SMN1; SMN2KMT2ANPC1RAB9AALDH1A1
SCHEMBL14887767 0.81 NAMPT (0.46) SCN9ASTIM1ORAI1POLQ
SCHEMBL16017210 0.80 MEN1 (0.50) SCN9ASMN1; SMN2KMT2AMEN1NPC1
SCHEMBL16017281 0.80 STIM1 (0.44) SCN9ASTIM1ORAI1TAS2R8POLQ
SCHEMBL14887347 0.79 RAB9A (0.58) SCN9ASTIM1ORAI1POLQADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 SCN9A 235/4885STIM1 17/4885ORAI1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback